Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma

被引：7
|
作者：
Serrao, Alessandra [1 ]
Canichella, Martina [1 ]
De Luca, Maria Lucia [1 ]
Tartaglia, Germana [1 ]
Annechini, Giorgia [1 ]
D'Elia, Gianna Maria [1 ]
Pulsoni, Alessandro [1 ]
机构：
[1] Sapienza Univ Rome, Dept Cellular Biotecnol & Hemathol, Via Benevento 6, I-00161 Rome, Italy
来源：
ANNALS OF HEMATOLOGY | 2019年 / 98卷 / 06期
关键词：
STEM-CELL TRANSPLANTATION; BRENTUXIMAB VEDOTIN; MULTICENTER;
D O I：
10.1007/s00277-018-3541-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1505 / 1506
页数：2
相关论文
共 50 条
  • [21] Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma
    Fedorova, Liudmila V.
    Lepik, Kirill V.
    Mikhailova, Natalia B.
    Kondakova, Elena V.
    Zalyalov, Yuri R.
    Baykov, Vadim V.
    Babenko, Elena V.
    Kozlov, Andrey V.
    Moiseev, Ivan S.
    Afanasyev, Boris V.
    ANNALS OF HEMATOLOGY, 2021, 100 (03) : 691 - 698
  • [22] Nivolumab is a safe and effective treatment of NSCLC
    Nature Reviews Clinical Oncology, 2015, 12 (5) : 250 - 250
  • [23] Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma
    Liudmila V. Fedorova
    Kirill V. Lepik
    Natalia B. Mikhailova
    Elena V. Kondakova
    Yuri R. Zalyalov
    Vadim V. Baykov
    Elena V. Babenko
    Andrey V. Kozlov
    Ivan S. Moiseev
    Boris V. Afanasyev
    Annals of Hematology, 2021, 100 : 691 - 698
  • [24] Nivolumab monotherapy in childhood refractory and relapsed Hodgkin's lymphoma
    Kozlov, A., V
    Kazantzev, I., V
    Iukhta, T., V
    Tolkunova, P. S.
    Zvyagintseva, D. A.
    Gevorgian, A. G.
    Morozova, E., V
    An, Schvecov
    Baykov, V. V.
    Punanov, Y. A.
    Mikhailova, N. B.
    Zubarovskaya, L. S.
    Afanasyev, B., V
    KLINISCHE PADIATRIE, 2020, 232 (02): : 82 - 82
  • [25] Nivolumab Is Tolerated and Effective in Post-Haploidentical HSCT Relapse of Refractory Hodgkin Lymphoma: A Case Report
    Shad, Aziza T.
    Huo, Jeffrey S.
    Darcy, Courtney
    Abu-Ghosh, Amal
    Esposito, Giuseppe
    Chen, Allen R.
    Llosa, Nicolas J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S232 - S232
  • [26] Interstitial nephritis associated with nivolumab in a patient with hodgkin lymphoma
    Oliveira, Deivide de Sousa
    Mesquita, Juliene Lima
    Oliveira Garcia, Yhasmine Delles
    Zelaya Rosales, Yensy Mariana
    Goncalves Lemes, Romelia Pinheiro
    Rocha Filho, Francisco Dario
    Branco Camurca Fernandes, Paula Frassinetti Castelo
    Araujo Duarte, Pastora Maria
    Pitombeira, Maria da Silva
    Duarte, Fernando Barroso
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (07): : 934 - 936
  • [27] Treatment of Relapsed/Refractory Hodgkin Lymphoma
    Chen, Robert W.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (02) : 6 - 9
  • [28] Nivolumab therapy for refractory and relapsed Hodgkin's lymphoma - case report
    Macioch, Marta
    Centkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (04): : 232 - 236
  • [29] Treatment of relapsed and refractory Hodgkin Lymphoma
    von Tresckow, Bastian
    Moskowitz, Craig H.
    SEMINARS IN HEMATOLOGY, 2016, 53 (03) : 180 - 185
  • [30] Combination of nivolumab with brentuximab vedotin in therapy of relapsed and refractory Hodgkin lymphoma
    Fedorova, L.
    Lepik, K.
    Mikhailova, N.
    Kondakova, E.
    Kotselyabina, P.
    Shmidt, D. I.
    Kozlov, A.
    Zalyalov, Y.
    Borzenkova, E.
    Baykov, V.
    Moiseev, I.
    Kulagin, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S655 - S655
12345